000			01830 a2200481 4500
005			20250516123340.0
264		0	_c20130723
008			201307s 0 0 eng d
022			_a1950-6007
024	7		_a10.1016/j.biopha.2012.10.016 _2doi
040			_aNLM _beng _cNLM
100	1		_aXin, J
245	0	0	_aApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells. _h[electronic resource]
260			_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cFeb 2013
300			_a88-95 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aFlow Cytometry
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGossypol _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aStomach Neoplasms _xdrug therapy
650	0	4	_aTime Factors
650	0	4	_aUp-Regulation _xdrug effects
650	0	4	_abcl-2-Associated X Protein _xgenetics
700	1		_aZhan, Y H
700	1		_aXia, L M
700	1		_aZhu, H W
700	1		_aNie, Y Z
700	1		_aLiang, J M
700	1		_aTian, J
773	0		_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 67 _gno. 1 _gp. 88-95
856	4	0	_uhttps://doi.org/10.1016/j.biopha.2012.10.016 _zAvailable from publisher's website
999			_c22309365 _d22309365